Cost-utility analysis of insulin glargine compared with NPH insulin in patients with type 1 diabetes in Spain

被引：0
|
作者：
Terrés, CR
Rodríguez, J
Bolinder, B
De Pablos, P
机构：
来源：
DIABETES | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A291 / A292
页数：2
相关论文
共 50 条
  • [31] A Randomized Clinical Trial of Insulin Glargine and Aspart, Compared to NPH and Regular Insulin in Children with Type 1 Diabetes Mellitus
    Rostami, Parastoo
    Setoodeh, Aria
    Rabbani, Ali
    Nakhaei-Moghadam, Maryam
    Najmi-Varzaneh, Farnaz
    Rezaei, Nima
    IRANIAN JOURNAL OF PEDIATRICS, 2014, 24 (02) : 173 - 178
  • [32] Lower within-subject variability of insulin detemir compared to NPH insulin and insulin glargine in subjects with Type 1 diabetes.
    Heise, T
    Nosek, L
    Draeger, E
    Ronn, BB
    Kapitza, C
    Heinemann, L
    DIABETOLOGIA, 2003, 46 : A6 - A7
  • [33] THE EFFECT OF GLARGINE AND NPH INSULIN IN PATIENTS WITH DIABETES MELLITUS TYPE 2
    Nechevska, L.
    Nechevski, M.
    Nechevska, E.
    Boskovski, B.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [34] COST-UTILITY ANALYSIS OF INSULIN GLARGINE 300 U/ML VERSUS INSULIN GLARGINE 100 U/ML AND INSULIN DEGLUDEC 100 U/ML IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CROATIA
    Bogdanovic, M.
    Fournier, M.
    Vitezic, D.
    VALUE IN HEALTH, 2018, 21 : S131 - S132
  • [35] Cost-Effectiveness Analysis of Insulin Detemir Compared to Neutral Protamine Hagedorn (NPH) in Patients with Type 1 and Type 2 Diabetes Mellitus in Spain
    Morales, Cristobal
    de Luis, Daniel
    Ramirez de Arellano, Antonio
    Giovanna Ferrario, Maria
    Lizan, Luis
    DIABETES THERAPY, 2015, 6 (04) : 593 - 610
  • [36] Cost-Effectiveness Analysis of Insulin Detemir Compared to Neutral Protamine Hagedorn (NPH) in Patients with Type 1 and Type 2 Diabetes Mellitus in Spain
    Cristóbal Morales
    Daniel de Luis
    Antonio Ramírez de Arellano
    Maria Giovanna Ferrario
    Luis Lizán
    Diabetes Therapy, 2015, 6 : 593 - 610
  • [37] COST-UTILITY ANALYSIS OF INSULIN GLARGINE 300 U/ML VERSUS INSULIN GLARGINE 100 U/ML AND INSULIN DEGLUDEC 100 U/ML IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN BULGARIA
    Bogdanovic, M.
    Mihajlovic, J.
    Fournier, M.
    VALUE IN HEALTH, 2018, 21 : S133 - S133
  • [38] Basal Insulin Regimens for Adults with Type 1 Diabetes Mellitus: A Cost-Utility Analysis
    Dawoud, Dalia
    Fenu, Elisabetta
    Higgins, Bernard
    Wonderling, David
    Amiel, Stephanie A.
    VALUE IN HEALTH, 2017, 20 (10) : 1279 - 1287
  • [39] Impact of diabetes duration on hypoglycaemia in patients with type 2 diabetes treated with insulin glargine or NPH insulin
    Dailey, G. E.
    Gao, L.
    Aurand, L.
    Garg, S. K.
    DIABETES OBESITY & METABOLISM, 2013, 15 (12): : 1085 - 1092
  • [40] HEALTH CARE COST AVOIDANCE DUE TO INSULIN GLARGINE FOR TYPE 2 DIABETIC PATIENTS IN HONG KONG AS COMPARED TO NPH INSULIN
    Lee, K. K.
    Wu, D. B. C.
    VALUE IN HEALTH, 2013, 16 (07) : A451 - A451
12345